Table of Contents Executive Summary 1 Industry Overview of Adrenoleukodystrophy Drugs 1.1 Definition of Adrenoleukodystrophy Drugs 1.2 Adrenoleukodystrophy Drugs Segment by Type 1.2.1 Global Adrenoleukodystrophy Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Biotin 1.2.3 DRX-065 1.2.4 DUOC-01 1.2.5 Lenti-D 1.2.6 MIN-102 1.2.7 OP-101 1.2.8 Others 1.3 Adrenoleukodystrophy Drugs Segment by Applications 1.3.1 Global Adrenoleukodystrophy Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Children 1.3.3 Adult 1.4 Global Adrenoleukodystrophy Drugs Overall Market 1.4.1 Global Adrenoleukodystrophy Drugs Revenue (2014-2025) 1.4.2 Global Adrenoleukodystrophy Drugs Production (2014-2025) 1.4.3 North America Adrenoleukodystrophy Drugs Status and Prospect (2014-2025) 1.4.4 Europe Adrenoleukodystrophy Drugs Status and Prospect (2014-2025) 1.4.5 China Adrenoleukodystrophy Drugs Status and Prospect (2014-2025) 1.4.6 Japan Adrenoleukodystrophy Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Adrenoleukodystrophy Drugs Status and Prospect (2014-2025) 1.4.8 India Adrenoleukodystrophy Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Adrenoleukodystrophy Drugs 2.3 Manufacturing Process Analysis of Adrenoleukodystrophy Drugs 2.4 Industry Chain Structure of Adrenoleukodystrophy Drugs 3 Development and Manufacturing Plants Analysis of Adrenoleukodystrophy Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Adrenoleukodystrophy Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Adrenoleukodystrophy Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Adrenoleukodystrophy Drugs Production and Capacity Analysis 4.2 Adrenoleukodystrophy Drugs Revenue Analysis 4.3 Adrenoleukodystrophy Drugs Price Analysis 4.4 Market Concentration Degree 5 Adrenoleukodystrophy Drugs Regional Market Analysis 5.1 Adrenoleukodystrophy Drugs Production by Regions 5.1.1 Global Adrenoleukodystrophy Drugs Production by Regions 5.1.2 Global Adrenoleukodystrophy Drugs Revenue by Regions 5.2 Adrenoleukodystrophy Drugs Consumption by Regions 5.3 North America Adrenoleukodystrophy Drugs Market Analysis 5.3.1 North America Adrenoleukodystrophy Drugs Production 5.3.2 North America Adrenoleukodystrophy Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Adrenoleukodystrophy Drugs Import and Export 5.4 Europe Adrenoleukodystrophy Drugs Market Analysis 5.4.1 Europe Adrenoleukodystrophy Drugs Production 5.4.2 Europe Adrenoleukodystrophy Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Adrenoleukodystrophy Drugs Import and Export 5.5 China Adrenoleukodystrophy Drugs Market Analysis 5.5.1 China Adrenoleukodystrophy Drugs Production 5.5.2 China Adrenoleukodystrophy Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Adrenoleukodystrophy Drugs Import and Export 5.6 Japan Adrenoleukodystrophy Drugs Market Analysis 5.6.1 Japan Adrenoleukodystrophy Drugs Production 5.6.2 Japan Adrenoleukodystrophy Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Adrenoleukodystrophy Drugs Import and Export 5.7 Southeast Asia Adrenoleukodystrophy Drugs Market Analysis 5.7.1 Southeast Asia Adrenoleukodystrophy Drugs Production 5.7.2 Southeast Asia Adrenoleukodystrophy Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Adrenoleukodystrophy Drugs Import and Export 5.8 India Adrenoleukodystrophy Drugs Market Analysis 5.8.1 India Adrenoleukodystrophy Drugs Production 5.8.2 India Adrenoleukodystrophy Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Adrenoleukodystrophy Drugs Import and Export 6 Adrenoleukodystrophy Drugs Segment Market Analysis (by Type) 6.1 Global Adrenoleukodystrophy Drugs Production by Type 6.2 Global Adrenoleukodystrophy Drugs Revenue by Type 6.3 Adrenoleukodystrophy Drugs Price by Type 7 Adrenoleukodystrophy Drugs Segment Market Analysis (by Application) 7.1 Global Adrenoleukodystrophy Drugs Consumption by Application 7.2 Global Adrenoleukodystrophy Drugs Consumption Market Share by Application (2014-2019) 8 Adrenoleukodystrophy Drugs Major Manufacturers Analysis 8.1 Applied Genetic Technologies Corp 8.1.1 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production Sites and Area Served 8.1.2 Applied Genetic Technologies Corp Product Introduction, Application and Specification 8.1.3 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Bluebird Bio Inc 8.2.1 Bluebird Bio Inc Adrenoleukodystrophy Drugs Production Sites and Area Served 8.2.2 Bluebird Bio Inc Product Introduction, Application and Specification 8.2.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 MedDay SA 8.3.1 MedDay SA Adrenoleukodystrophy Drugs Production Sites and Area Served 8.3.2 MedDay SA Product Introduction, Application and Specification 8.3.3 MedDay SA Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Minoryx Therapeutics sl 8.4.1 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production Sites and Area Served 8.4.2 Minoryx Therapeutics sl Product Introduction, Application and Specification 8.4.3 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Pfizer Inc 8.5.1 Pfizer Inc Adrenoleukodystrophy Drugs Production Sites and Area Served 8.5.2 Pfizer Inc Product Introduction, Application and Specification 8.5.3 Pfizer Inc Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 ReceptoPharm Inc 8.6.1 ReceptoPharm Inc Adrenoleukodystrophy Drugs Production Sites and Area Served 8.6.2 ReceptoPharm Inc Product Introduction, Application and Specification 8.6.3 ReceptoPharm Inc Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 SOM Biotech SL 8.7.1 SOM Biotech SL Adrenoleukodystrophy Drugs Production Sites and Area Served 8.7.2 SOM Biotech SL Product Introduction, Application and Specification 8.7.3 SOM Biotech SL Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Viking Therapeutics Inc 8.8.1 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production Sites and Area Served 8.8.2 Viking Therapeutics Inc Product Introduction, Application and Specification 8.8.3 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 9 Development Trend of Analysis of Adrenoleukodystrophy Drugs Market 9.1 Global Adrenoleukodystrophy Drugs Market Trend Analysis 9.1.1 Global Adrenoleukodystrophy Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Adrenoleukodystrophy Drugs Regional Market Trend 9.2.1 North America Adrenoleukodystrophy Drugs Forecast 2019-2025 9.2.2 Europe Adrenoleukodystrophy Drugs Forecast 2019-2025 9.2.3 China Adrenoleukodystrophy Drugs Forecast 2019-2025 9.2.4 Japan Adrenoleukodystrophy Drugs Forecast 2019-2025 9.2.5 Southeast Asia Adrenoleukodystrophy Drugs Forecast 2019-2025 9.2.6 India Adrenoleukodystrophy Drugs Forecast 2019-2025 9.3 Adrenoleukodystrophy Drugs Market Trend (Product Type) 9.4 Adrenoleukodystrophy Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Adrenoleukodystrophy Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Adrenoleukodystrophy Drugs Table Global Adrenoleukodystrophy Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Adrenoleukodystrophy Drugs Production Market Share by Types in 2018 Figure Biotin Product Picture Figure DRX-065 Product Picture Figure DUOC-01 Product Picture Figure Lenti-D Product Picture Figure MIN-102 Product Picture Figure OP-101 Product Picture Figure Others Product Picture Table Global Adrenoleukodystrophy Drugs Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Adrenoleukodystrophy Drugs Consumption Market Share by Applications in 2018 Figure Children Figure Adult Figure Global Adrenoleukodystrophy Drugs Revenue (Million USD) (2014-2025) Figure Global Adrenoleukodystrophy Drugs Production (K Pcs) (2014-2025) Figure North America Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025) Figure Europe Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025) Figure China Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025) Figure Japan Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025) Figure India Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025) Table Adrenoleukodystrophy Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Adrenoleukodystrophy Drugs in 2018 Figure Manufacturing Process Analysis of Adrenoleukodystrophy Drugs Figure Industry Chain Structure of Adrenoleukodystrophy Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Adrenoleukodystrophy Drugs Manufacturing Plants Distribution Table Adrenoleukodystrophy Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Adrenoleukodystrophy Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Adrenoleukodystrophy Drugs Production (K Pcs) of Major Manufacturers (2014-2019) Table Adrenoleukodystrophy Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Adrenoleukodystrophy Drugs Production Share by Manufacturers in 2018 Table Adrenoleukodystrophy Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Adrenoleukodystrophy Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Adrenoleukodystrophy Drugs Revenue Share by Manufacturers in 2018 Table Adrenoleukodystrophy Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Adrenoleukodystrophy Drugs Production by Regions 2014-2019 (K Pcs) Table Global Adrenoleukodystrophy Drugs Production Market Share by Regions 2014-2019 Figure Global Adrenoleukodystrophy Drugs Production Market Share by Regions in 2018 Table Global Adrenoleukodystrophy Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Adrenoleukodystrophy Drugs Revenue Market Share by Regions 2014-2019 Figure Global Adrenoleukodystrophy Drugs Revenue Market Share by Regions in 2018 Table Global Adrenoleukodystrophy Drugs Consumption by Regions 2014-2019 (K Pcs) Table Global Adrenoleukodystrophy Drugs Consumption Market Share by Regions 2014-2019 Figure North America Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs) Figure North America Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs) Figure Europe Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs) Figure Europe Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs) Figure China Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs) Figure China Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs) Figure Japan Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs) Figure Japan Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs) Figure India Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs) Figure India Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs) Figure Global Consumption Adrenoleukodystrophy Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Adrenoleukodystrophy Drugs Market Share by Application (2014-2019) Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production Sites and Area Served Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Product Introduction, Application and Specification Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019) Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production Market Share (2014-2019) Figure Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019) Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Main Business and Markets Served Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Production Sites and Area Served Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Product Introduction, Application and Specification Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019) Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Production Market Share (2014-2019) Figure Bluebird Bio Inc Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019) Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Main Business and Markets Served Table MedDay SA Adrenoleukodystrophy Drugs Production Sites and Area Served Table MedDay SA Adrenoleukodystrophy Drugs Product Introduction, Application and Specification Table MedDay SA Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table MedDay SA Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019) Table MedDay SA Adrenoleukodystrophy Drugs Production Market Share (2014-2019) Figure MedDay SA Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019) Table MedDay SA Adrenoleukodystrophy Drugs Main Business and Markets Served Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production Sites and Area Served Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Product Introduction, Application and Specification Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019) Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production Market Share (2014-2019) Figure Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019) Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Main Business and Markets Served Table Pfizer Inc Adrenoleukodystrophy Drugs Production Sites and Area Served Table Pfizer Inc Adrenoleukodystrophy Drugs Product Introduction, Application and Specification Table Pfizer Inc Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Pfizer Inc Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019) Table Pfizer Inc Adrenoleukodystrophy Drugs Production Market Share (2014-2019) Figure Pfizer Inc Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019) Table Pfizer Inc Adrenoleukodystrophy Drugs Main Business and Markets Served Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Production Sites and Area Served Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Product Introduction, Application and Specification Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019) Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Production Market Share (2014-2019) Figure ReceptoPharm Inc Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019) Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Main Business and Markets Served Table SOM Biotech SL Adrenoleukodystrophy Drugs Production Sites and Area Served Table SOM Biotech SL Adrenoleukodystrophy Drugs Product Introduction, Application and Specification Table SOM Biotech SL Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table SOM Biotech SL Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019) Table SOM Biotech SL Adrenoleukodystrophy Drugs Production Market Share (2014-2019) Figure SOM Biotech SL Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019) Table SOM Biotech SL Adrenoleukodystrophy Drugs Main Business and Markets Served Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production Sites and Area Served Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Product Introduction, Application and Specification Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019) Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production Market Share (2014-2019) Figure Viking Therapeutics Inc Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019) Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Main Business and Markets Served Figure Global Adrenoleukodystrophy Drugs Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Adrenoleukodystrophy Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Adrenoleukodystrophy Drugs by Type (2019-2025) Table Global Consumption (K Pcs) of Adrenoleukodystrophy Drugs by Application (2019-2025) Table Adrenoleukodystrophy Drugs Distributors List Table Adrenoleukodystrophy Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Applied Genetic Technologies Corp Bluebird Bio Inc MedDay SA Minoryx Therapeutics sl Pfizer Inc ReceptoPharm Inc SOM Biotech SL Viking Therapeutics Inc